Saidal

Saidal Group is an Algerian pharmaceutical company created in 1982. Saidal Group is the largest pharmaceutical company in Algeria and one of the largest in Africa.

Saidal Group
Native name
مجمع صيدال
TypeState-owned company
Industrypharmaceuticals
Founded1982 (1982)
Headquarters,
Productsantibiotics, generics
Production output
pharmaceuticals
RevenueUS$982 million (2006)
Number of employees
4,300 (2006)
Websitewww.saidalgroup.dz

Saidal Group exports its products to Ivory Coast, Gabon, Senegal, Cameroon, Mali, Democratic Republic of the Congo, Republic of the Congo, Niger, Togo, Benin, Guinea-Bissau, Chad and Mauritania.[1]

History

Saïdal was created in April 1982 following the restructuring of the Algerian Central Pharmacy. In 1985, it changed its name to become Saidal.

In 1989, Saidal became an economic public company, one of the first national company to acquire the status of joint stock company in 1993. In 1997, Saidal was transformed into an industrial group, which Biotic, Pharmal and Antibiotical were attached.[2]

January 4, 2016, the national bioequivalence center, the first in Algeria, was inaugurated by the Minister of Industry and Mines, Abdeslam Bouchouareb.[3]

Company management

Saïdal is headed by :

  • Boumediene Derkaoui (2010-2015)
  • Mohamed Hammouche (2015-2016)
  • Yacine Tounsi (2016-2017)
  • Mohamed Nouas (2017-2020)
  • Fatouma Akacem since February 11, 2020[4]

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.